All lobbying filings

TIBER CREEK GROUP

Lobbying for BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.) · Biopharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $70,000.00 income · posted Jan 17, 2026

Official filing document

Bills named in this filing 2

HR 946
ORPHAN Cures Act
S 1862
ORPHAN Cures Act

Lobbying activity 3

Health Issues

Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act; Issues related to the One Big Beautiful Bill Act (PL 119-21).

Medicare/Medicaid

Issues related to drug pricing and reimbursement for prescription drugs related to the Inflation Reduction Act of 2022 (PL 117-169), Subtitle B (Part B and D drug pricing); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21).

Budget/Appropriations

Issues related to Centers for Medicare and Medicaid.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.